Scientists at MIT have developed “a machine learning model that can capture how sounds in a room will propagate through space,” report Kyle Wiggers and Devin Coldewey for TechCrunch. “By modeling the acoustics, the system can learn a room’s geometry from sound recordings, which can then be used to build a visual rendering of a room,” write Wiggers and Coldewey.
CNBC reporter Catherine Clifford spotlights C16 Biosciences, a startup co-founded by MIT alumni that is developing a palm oil alternative called Palmless. “What we are building is a platform technology that can produce all different kinds of microbial oils,” explains David Heller ’18, co-founder and head of operations at C16 Biosciences. “It’s definitely possible that we’re able to make other kinds of vegetable oil replacements in the future.”
MIT researchers have developed a new machine learning model that can identify and track blobs of plasma created in controlled nuclear-fusion research, reports Ed Browne for Newsweek. “Fusion research is a complex, multidisciplinary project that requires technologies from many fields,” explains graduate student Woonghee “Harry” Han.
QuEra Computing, a cloud-based quantum computer service co-founded by faculty from MIT and Harvard, has “teamed up with Amazon’s AWS cloud service to sell online access to the device,” reports Hiawatha Bray for The Boston Globe. The device “can be used by universities and corporate researchers worldwide for a variety of advanced tasks, like simulating the behavior of subatomic particles or developing new chemical compounds,” writes Bray.
Prof. Kripa Varanasi and his colleagues have founded Alsym Energy, a startup working toward developing a lithium battery alternative, reports Hiawatha Bray for The Boston Globe. The founders say “they’ve built a new kind of rechargeable battery that delivers the performance of lithium ion cells at half the cost,” writes Bray.
QuEra, co-founded by faculty from MIT and Harvard, is a quantum computing startup that uses “neutral atoms in a vacuum chamber and use lasers to cool and control them,” reports Jane Lanhee Lee for Reuters. The startup has announced its “computer is now accessible to the public through Amazon.com cloud’s quantum compute service Braket,” writes Lee.
Principal research scientist Leo Anthony Celi speaks with Associated Press reporter Maddie Burakoff about how pulse oximeters can provide inaccurate readings in patients of color. Celi highlights how oxygen levels can also be measured by drawing blood out of an artery in the wrist, the “gold standard” for accuracy, but a method that is a a bit trickier and more painful.
Postdoctoral fellow Suhas Eswarappa Prameela speaks with Science Careers about how to develop and maintain successful relationships with advisors, mentors, and supervisors. “Faculty members are inundated with multiple administrative, teaching, and service activities, so being proactive, articulating your needs, and clearly communicating hurdles in the lab is key,” notes Prameela.
Writing for The Boston Globe, Prof. Linda Griffith underscores the pressing need to invest in studying women’s health and menstruation science. “These were the attitudes society had about breast cancer decades ago; we didn’t talk about it. But then we finally focused on the science, and overcame the squeamishness about mentioning ‘breasts’ by creating a technical language that could be spoken without hesitation by anyone,” writes Griffith. “We need a similar scientific push for menstruation science, and a comfort level with the language that goes with it. It’s time.”
Jamie Karraker BS ’12 MS ’13 co-founded Alto Pharmacy – a full-service, online pharmacy that aims to create a transparent, straightforward and user-friendly experience, reports Erika Fry for Fortune. “All patients need to do after seeing their doctor is interface with the app (or via text) and pick up the prescription from their front door,” writes Fry.
Landmark Bio, a cell and gene therapy manufacturing company co-founded by MIT and a number of other institutions, is focused on accelerating access to innovative therapies for patients, reports Rowan Walrath for Boston Business Journal. "Landmark's new facility includes laboratory space for research and early-stage drug development, as well as analytics tools,” writes Walrath.
MIT and a number of other local institutions have launched Landmark Bio, a cell and gene therapy manufacturing firm aimed at helping small startups develop experimental therapies that are reliable, consistent, and large enough to be used in clinical trials, reports Ryan Cross for The Boston Globe.
Prof. Daniela Rus, director of CSAIL, speaks with Forbes reporter John Koetsier about the future of robotics. “I have been on a quest to have universal machines,” says Rus. “My idea is to create universal robot cells that could combine to form different types of machines, each with the same capability.”
Ash Carter, a member of the MIT Corporation and innovation fellow, has died at the at the age of 68, reports Tara Copp for Associated Press. Carter – who opened combat jobs to women and ended the ban on transgender people serving in the military – was known “as a defensive thinker and strategist,” writes Copp.
Researchers at MIT are working on a system that can track the development of Parkinson’s disease by monitoring a person’s gait speed, reports Kyle Wiggers and Devin Coldewey for TechCrunch. “The MIT Parkinson’s-tracking effort aims to help clinicians overcome challenges in treating the estimated 10 million people afflicted by the disease globally,” writes Wiggers and Coldewey.